Type 2 diabetes can be put into remission, and a meaningful percentage of people have done it through weight loss, dietary changes, or surgery. Type 1 diabetes cannot currently be reversed, though transplant procedures and newer therapies offer partial solutions. The distinction matters: remission means your blood sugar returns to normal levels without medication for at least three months, but it requires ongoing maintenance and can relapse.
What “Remission” Actually Means
Doctors don’t typically use the word “cured” for diabetes. The agreed-upon term is remission, defined as an HbA1c (a measure of average blood sugar over three months) below 6.5% that lasts at least three months without any glucose-lowering medication. That threshold is the same number used to diagnose diabetes in the first place, so remission essentially means your blood sugar no longer meets the diagnostic criteria.
This distinction isn’t just semantic. Even after achieving remission, the underlying tendency toward insulin resistance or impaired insulin production doesn’t fully disappear. Your body got to that point for biological reasons, whether genetic, autoimmune, or metabolic, and those factors remain in the background. That’s why sustained effort matters so much.
Weight Loss Is the Most Proven Path for Type 2
The strongest evidence for reversing type 2 diabetes comes from weight loss. In the landmark DiRECT trial, a structured weight management program in the UK, the results scaled dramatically with how much weight participants lost. At 12 and 24 months, over 80% of participants who lost more than 15 kilograms (about 33 pounds) were in remission. Among those who maintained a loss of more than 10 kilograms (22 pounds), 75% achieved remission.
Those numbers are remarkable, but they come with a caveat about maintenance. A large Kaiser Permanente study tracking over 16,000 adults who achieved remission found that nearly 37% needed to restart medication within the following three years. Weight regain was a primary driver. Remission, in practice, isn’t a one-time achievement. It’s a state you maintain.
The amount of weight you need to lose depends on where you started and how long you’ve had diabetes. People diagnosed more recently tend to respond better, likely because their insulin-producing cells haven’t been damaged as extensively. If you’ve had type 2 diabetes for a decade or more, remission is harder but not impossible.
Low-Carb Diets Show Short-Term Results
Low-carbohydrate diets have gotten significant attention as a way to bring blood sugar under control quickly, and the short-term data is genuinely impressive. A large meta-analysis in The BMJ pooled results from 23 randomized trials and found that at six months, 57% of people on low-carb diets achieved an HbA1c below 6.5%, compared to 31% on standard diets. For people not using insulin, the results were even more striking: for every two people who tried a low-carb approach, one achieved remission by the HbA1c threshold.
The catch is durability. By 12 months, the advantage over standard diets had shrunk considerably. The blood sugar benefit was roughly half of what it had been at six months, and the weight loss difference between low-carb and control diets was essentially zero. This pattern suggests that low-carb diets work well for an initial reset, but long-term success depends on whether you can sustain the approach or transition to another strategy that keeps weight off.
Safety appears reasonable. Pooled data showed no significant increase in serious side effects from low-carb eating. One important finding: people already using insulin saw much smaller benefits, suggesting that low-carb diets work best earlier in the disease when your body still produces meaningful amounts of its own insulin.
Bariatric Surgery Offers Stronger, Longer Results
For people with obesity and type 2 diabetes who haven’t achieved remission through diet and exercise alone, bariatric surgery is the most effective single intervention available. Among 677 patients with diabetes who underwent gastric bypass, 54% were in remission at three years. At 15 years, that number had declined to 38%, which still represents a substantial proportion maintaining normal blood sugar without medication for over a decade.
The results depend heavily on how advanced your diabetes was before surgery. Only about 10% of patients who were on insulin before the procedure achieved remission. The rate of persistent diabetes was significantly higher in this group. This reinforces a broader pattern across all treatment approaches: earlier intervention works better. The longer diabetes has been present and the more medication you need, the harder remission becomes.
Surgery also carries its own risks and requires permanent dietary changes, so it’s typically considered after other approaches have been tried or when someone’s BMI and health profile make it the most practical option.
Type 1 Diabetes Is a Different Problem
Type 1 diabetes is an autoimmune condition where your immune system destroys the cells in your pancreas that produce insulin. Unlike type 2, it isn’t driven by weight or lifestyle, and no amount of diet change or exercise can reverse it. The insulin-producing cells are gone, and your body continues to attack any new ones.
That said, there are two approaches that can reduce or eliminate the need for insulin injections, at least temporarily.
Pancreas and Islet Cell Transplants
A whole-organ pancreas transplant is the closest thing to a functional cure for type 1 diabetes. Graft survival rates are high: about 98.5% at one year and 88.5% at five years. Recipients who maintain a functioning graft don’t need insulin at all. The tradeoff is that you’ll need lifelong immunosuppressive drugs to prevent your body from rejecting the transplanted organ, and those drugs carry their own health risks including increased susceptibility to infections and certain cancers.
Islet cell transplantation is a less invasive alternative where just the insulin-producing cell clusters are transplanted rather than the entire organ. A majority of recipients at experienced centers achieve insulin independence within the first year. The challenge is longevity. Early studies showed rapid loss of insulin independence beyond one year in many patients. With newer, more potent immune-suppressing protocols, five-year insulin independence rates have improved to around 50% at specialized centers, comparable to whole-pancreas transplant outcomes. But with older or less aggressive protocols, five-year independence rates dropped as low as 0% to 20%.
Both transplant options are limited by organ availability and reserved for people with severe, hard-to-manage type 1 diabetes. They’re not routine treatments.
Delaying Type 1 Onset
For people identified as high-risk for type 1 diabetes (through antibody testing, often in family members of people with the disease), a newer therapy can delay the onset significantly. Teplizumab, an immune-modulating drug approved in 2022, delayed the clinical onset of type 1 diabetes by an average of about 32 months compared to untreated individuals. Treated individuals went nearly five years before developing full diabetes, compared to just over two years without treatment. It also halved the rate of diagnoses during the study period. This doesn’t prevent type 1 diabetes, but buying years before someone needs daily insulin management is meaningful, especially for children.
What Determines Your Chances
Across every approach for type 2 diabetes, a few factors consistently predict who achieves remission and who doesn’t. Shorter duration of diabetes is the single most important one. People diagnosed within the last few years respond far better than those who’ve had it for a decade. Lower pre-treatment medication burden matters too: if you’re managing with diet alone or a single oral medication, your odds are substantially better than if you’re already on insulin. And the amount of weight lost correlates directly with remission rates, with the sharpest benefits appearing above the 10-kilogram mark.
For type 1 diabetes, the calculus is different. Your options are currently limited to transplantation (with its requirement for lifelong immunosuppression) or delay strategies for those not yet diagnosed. The autoimmune destruction at the core of type 1 doesn’t have a reversal pathway yet, though cell-based therapies are an active area of development.
If you have type 2 diabetes and are considering pursuing remission, the most actionable step is sustained weight loss of at least 10 to 15 kilograms, ideally through a structured program with ongoing support. The earlier you start, the better your chances, and the more important it becomes to maintain whatever changes got you there.